The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer

Autor: Zhang Shangfu, Ma Junliang, Pu Qiang, Yu Nanbin, Che Guowei, Liu Lunxu, Dai Fuqiang, Ma Lin, You Zongbing

Publikováno v: BMC Cancer, Vol 10, Iss 1, p 220 (2010)

Abstract Background Tumor microenvironment is composed of tumor cells, fibroblasts, endothelial cells, and infiltrating immune cells. Tumor-associated immune cells may inhibit or promote tumor growth and progression. This study was conducted to deter

Externí odkaz: https://doaj.org/article/7bbaf2cbcaa040c89b78995eb1745522

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Comparison of Quality of Life of the Patients Three Months after Uniportal 
and Multiportal Thoracoscopic Lobectomy].

Autor: Zhang Q; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China., Dai W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Wei X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Xiang R; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Gu H; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Hu P; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Liu M; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Chen W; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China., Gong H; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China., Liang Y; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China., Zhang S; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China., Peng W; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China., Shi Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Li Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of 
University of Electronic Science and Technology of China, Chengdu 610041, China., Yu N; Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.

Publikováno v: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2023 Nov 20; Vol. 26 (11), pp. 843-850.